Clinical trial
Study of Antidepressants in Parkinson's Disease
NCT00086190
Study timeline
Study start (unknown)2005-06-01Date precision: month
Registry last updated2013-01-04
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Parkinson Diseaseunresolved
Depressionunresolved
Interventions
paroxetineDRUG · verified · RxNorm: paroxetine
venlafaxineDRUG · verified · RxNorm: venlafaxine
placeboOTHER
Sponsors & collaborators
University of Rochesterlead sponsor
Mapped research locations
BaltimoreMaryland, United States2HoustonTexas, United States1BostonMassachusetts, United States1St LouisMissouri, United States1AtlantaGeorgia, United States1MiamiFlorida, United States1San FranciscoCalifornia, United States1PortlandOregon, United States1MontrealQuebec, Canada1RochesterNew York, United States1MemphisTennessee, United States1LexingtonKentucky, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00086190 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.